StockGuru Blog: RxElite (SOUT) – Twelve Crucial Facts on Exclusive Sevofurane Distribution Rights
Sevoflurane Goes Generic and RxElite Is Up and Running! Stock Guru Profile 1. RxElite has THE PRODUCT — the most widely used inhalable anesthetic in the world — AND the U.S. distribution rights for that product. 2. Sevoflurane whose Minrad trade name is Sojourn(TM) is THE modern generic anesthetic. 3. The US market is estimated to be a $400M opportunity. 4. RxElite is the exclusive commercial partner in the US for Minrad International Inc. (Minrad) (Amex: BUF - News), who announced in May that the U.S. Food and Drug Administration had given its approval to market its generic version…